Laboratory Medicine
Test catalogue
| Emicizumab (Hemlibra) | |
|---|---|
| Test NameEmicizumab (Hemlibra) | |
| 
   		    
   		     | |
| Specimen HandlingCollection Instructions: Must indicate anticoagulant status to avoid delay. A Hematology consult is REQUIRED for inpatient samples (except for patients in Hematology/Oncology ward). Referred-in patients and outpatients can be tested without a Hematology consult. Write your initials, date and time of collection on the collection label. Transportation: In/Outpatients: Send whole citrated blood at room temperature as soon as possible. Referred-in: Send frozen citrated plasma on dry ice. All samples must be sent to the Core Laboratory. Stability: Specimens are stable for 4 hours post collection at room temperature. Specimens which are not tested within 4 hours can be double-spun to remove the citrated plasma. The citrated plasma is stable at -20°C for up to two weeks or -70°C for up to six months. Sample Rejection Criteria: Clotted sample, grossly hemolyzed samples, unlabeled or samples with insufficient quantity will be rejected. | |
| Required Documentation | |
| Turnaround Time (TAT)7 days | Test Utilization | 
| Reference ValueSee Interpretive Comment | |
| Test CodeEMI | MethodologyClotting Assay | 
| Testing LocationSMH-Special Coagulation | Other InformationLast Updated: April 12, 2022 
 | 
 Specimen Type / Requirements
				   		    
   		    
   		    Specimen Type / Requirements